Development of an mRNA-based therapeutic vaccine mHTV-03E2 for high-risk HPV-related malignancies.
Wang J, Wang Q, Ma L, Lv K, Han L, Chen Y, Zhou R, Zhou H, Chen H, Wang Y, Zhang T, Yi D, Liu Q, Zhang Y, Li X, Cheng T, Zhang J, Huang C, Dong Y, Zhang W, Cen S.
Wang J, et al. Among authors: cen s.
Mol Ther. 2024 Jul 3;32(7):2340-2356. doi: 10.1016/j.ymthe.2024.04.036. Epub 2024 May 6.
Mol Ther. 2024.
PMID: 38715363